Results 111 to 120 of about 35,795 (270)

Partial ileal bypass as treatment of ileal obstruction: short and long term follow-up in 8 cases

open access: yes, 2014
The study describes short and long follow up and possible complications in a group of horses underwent to explorative laparotomy and jejunocaecostomy with partial pybass after diagnosis of ileal obstruction secondary to different ...
DI MEO, Antonio   +9 more
core  

Protective Effects of Beta-3 Adrenoceptor Agonism on Mucosal Integrity in Hyperoxia-Induced Ileal Alterations

open access: yesAntioxidants
Organogenesis occurs in the uterus under low oxygen levels (4%). Preterm birth exposes immature newborns to a hyperoxic environment, which can induce a massive production of reactive oxygen species and potentially affect organ development, leading to ...
Patrizia Nardini   +12 more
doaj   +1 more source

Prognosis after ileal resection for Crohn's disease

open access: yesJournal of British Surgery, 1971
Abstract The recurrence rate in a series of 62 patients who underwent first resections for Crohn's disease of the ileum was determined by an actuarial method. After 5 years the recurrence rate was 18 per cent, and at 10 years it was 33 per cent. The prognosis was least favourable in young females with short clinical histories. The E.S.R.,
openaire   +2 more sources

Sulfasalazine in Prevention of Pouchitis After Proctocolectomy with Ileal Pouch–Anal Anastomosis for Ulcerative Colitis

open access: yes, 2017
Background: Pouchitis is the most frequent complication after ileal pouch–anal anastomosis for refractory ulcerative colitis. A non-standardized preventative treatment exists. Sulfasalazine has proved effective in acute pouchitis therapy.
SCAIOLI, ELEONORA   +9 more
core   +1 more source

Save the Bladder: Continent Urinary Diversion as Best Practice for Patients With Refractory Neurogenic Lower Urinary Tract Dysfunction

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Refractory neurogenic lower urinary tract dysfunction presents an obstinate clinical problem. For patients who fail nonsurgical measures, we advocate for bladder‐sparing, continent urinary diversion as the optimal approach to management.
Brian W. Chao, Sean P. Elliott
wiley   +1 more source

The role of ultrasound elasticity imaging in predicting ileal fibrosis in Crohn's disease patients

open access: yes, 2015
Backgound: Bowel wall fibrosis is associated with a complicated disease behavior in patients with Crohn's disease (CD). The quantitative assessment of fibrosis severity in CD-affected bowel can help clinical decision making.
D. Conte   +11 more
core   +1 more source

Endoscopic small bowel therapies for type 2 diabetes

open access: yesNutrition in Clinical Practice, EarlyView.
Abstract Type 2 diabetes is a global epidemic despite current medical treatments. Many patients are not responsive to medications, and patients with obesity are hesitant about bariatric surgery. Studies investigating the metabolic effects of Roux‐en‐Y gastric bypass have increasingly demonstrated that the duodenum plays a key role in the ...
Roma Patel   +4 more
wiley   +1 more source

Physiology and pathophysiology of the ileal brake in humans

open access: yes, 2007
The ileal brake is an intraluminal nutrient-triggered feedback control from the distal to the proximal gut with fat being the most potent trigger. Peptide YY (PYY) is one of the hormonal mediators of the ileal brake.
Vu, M.K.
core  

Intracellular galectin-9 enhances proximal TCR signaling and potentiates autoimmune diseases

open access: yes, 2020
[[abstract]]Galectin-9 is a risk gene in inflammatory bowel disease. By transcriptomic analyses of ileal biopsies and PBMCs from inflammatory bowel disease patients, we identified a positive correlation between galectin-9 expression and colitis severity.
Chen, HY;Wu, YF;Chou, FC;Wu, YH;Yeh, LT;Lin, KI;Liu, FT;Sytwu, HK
core   +1 more source

Single‐center experience of the Crohn's disease exclusion diet in the United States: A retrospective study

open access: yesNutrition in Clinical Practice, EarlyView.
Abstract Background The Crohn's Disease Exclusion Diet (CDED) offers a dietary means of inducing and maintaining remission for patients with Crohn's disease (CD). Descriptions of efficacy have emerged primarily from Israel, Europe, and Canada. Here, we offer real‐world experience, from a tertiary care center in the United States. Methods We conducted a
Mayah Greenfield   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy